The 8 analysts offering 12-month price forecasts for Akero Therapeutics Inc have a median target of 59.50, with a high estimate of 81.00 and a low estimate of 46.00. The median estimate represents a +116.44% increase from the last price of 27.49.
The current consensus among 8 polled investment analysts is to Buy stock in Akero Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.90
Reporting Date May 19
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.